Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats

Behavioural Brain Research

Volumn 222, Issue 1, 2011, Pages 230-235

  Grillo, Claudia A ^a   Piroli, Gerardo G ^a   Kaigler, Kris F ^a   Wilson, Steven P ^a   Wilson, Marlene A ^a   Reagan, Lawrence P ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Anhedonia; Brain derived neurotrophic factor; Elevated plus maze; Forced swim test; Leptin; Obesity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INSULIN RECEPTOR; LENTIVIRUS VECTOR; SUCROSE;

AMYGDALOID NUCLEUS; ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISENSE VECTOR; ANXIETY DISORDER; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL TEST; FORCED SWIMMING TEST; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; IMMOBILIZATION; MALE; MAZE TEST; NEUROPATHOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR DOWN REGULATION; SUCROSE PREFERENCE TEST; SUGAR INTAKE; TASK PERFORMANCE;

ADIPOSITY; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DEPRESSION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FOOD PREFERENCES; GENETIC VECTORS; HYPOTHALAMUS; LEPTIN; MALE; MAZE LEARNING; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SWIMMING; TRIGLYCERIDES;

EID: 79955013424     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.052     Document Type: Article

References (65)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Morley J.E., Banks W.A. Lipids and cognition. J Alzheimers Dis 2010, 20:737-747.
3. Benoit S.C., Davis J.F., Davidson T.L. Learned and cognitive controls of food intake. Brain Res 2010, 1350:71-76.
4. Simon G.E., Von Korff M., Saunders K., Miglioretti D.L., Crane P.K., van Belle G., et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006, 63:824-830.
5. de Wit L., Luppino F., van Straten A., Penninx B., Zitman F., Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res 2010.
6. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010, 67:220-229.
7. Onyike C.U., Crum R.M., Lee H.B., Lyketsos C.G., Eaton W.W. Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003, 158:1139-1147.
8. Fabricatore A.N., Wadden T.A. Obesity. Annu Rev Clin Psychol 2006, 2:357-377.
9. McElroy S.L., Kotwal R., Malhotra S., Nelson E.B., Keck P.E., Nemeroff C.B. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 2004, 65:634-651. quiz.
10. Roberts R.E., Deleger S., Strawbridge W.J., Kaplan G.A. Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord 2003, 27:514-521.
11. Goldfield G.S., Moore C., Henderson K., Buchholz A., Obeid N., Flament M.F. Body dissatisfaction, dietary restraint, depression, and weight status in adolescents. J Sch Health 2010, 80:186-192.
12. Sarwer D.B., Wadden T.A., Fabricatore A.N. Psychosocial and behavioral aspects of bariatric surgery. Obes Res 2005, 13:639-648.
13. Andersen J.R., Aasprang A., Bergsholm P., Sletteskog N., Vage V., Natvig G.K. Anxiety and depression in association with morbid obesity: changes with improved physical health after duodenal switch. Health Qual Life Outcomes 2010, 8:52.
14. Stunkard A.J., Faith M.S., Allison K.C. Depression and obesity. Biol Psychiatry 2003, 54:330-337.
15. Malone M., Alger-Mayer S.A., Anderson D.A. The lifestyle challenge program: a multidisciplinary approach to weight management. Ann Pharmacother 2005, 39:2015-2020.
16. Banks W.A. The many lives of leptin. Peptides 2004, 25:331-338.
17. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
18. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 2007, 7:643-647.
19. Harvey J., Shanley L.J., O'Malley D., Irving A.J. Leptin: a potential cognitive enhancer?. Biochem Soc Trans 2005, 33:1029-1032.
20. Harvey J. Novel actions of leptin in the hippocampus. Ann Med 2003, 35:197-206.
21. Burguera B., Couce M.E., Curran G.L., Jensen M.D., Lloyd R.V., Cleary M.P., et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 2000, 49:1219-1223.
22. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20:1341-1345.
23. Harvey J., Solovyova N., Irving A. Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res 2006, 45:369-378.
24. Lu X.Y. The leptin hypothesis of depression: a potential link between mood disorders and obesity?. Curr Opin Pharmacol 2007, 7:648-652.
25. Grillo C.A., Tamashiro K.L., Piroli G.G., Melhorn S., Gass J.T., Newsom R.J., et al. Lentivirus-mediated downregulation of hypothalamic insulin receptor expression. Physiol Behav 2007, 92:691-701.
26. Grillo C.A., Piroli G.G., Evans A.N., Macht V.A., Wilson S.P., Scott K.A., et al. Obesity/hyperleptinemic phenotype adversely affects hippocampal plasticity: effects of dietary restriction. Physiol Behav 2010.
27. Wilson M.A., Junor L. The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models. Neuropsychopharmacology 2008, 33:2957-2968.
28. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 2005, 30:1589-1597.
29. Primeaux S.D., Wilson S.P., McDonald A.J., Mascagni F., Wilson M.A. The role of delta opioid receptors in the anxiolytic actions of benzodiazepines. Pharmacol Biochem Behav 2006, 85:545-554.
30. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats: a new model sensitive to anti-depressant treatments. Eur J Pharmacol 1977, 47:379.
31. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature (Lond) 1977, 266:730-732.
32. Reagan L.P., Rosell D.R., Wood G.E., Spedding M., Munoz C., Rothstein J., et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 2004, 101:2179-2184.
33. Reagan L.P., Hendry R.M., Reznikov L.R., Piroli G.G., Wood G.E., McEwen B.S., et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol 2007, 565:68-75.
34. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry 2002, 7(Suppl. 1):S29-S34.
35. Park H.R., Park M., Choi J., Park K.Y., Chung H.Y., Lee J. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 2010, 482:235-239.
36. Shanley L.J., Irving A.J., Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 2001, 21:art-RC186.
37. O'Malley D., MacDonald N., Mizielinska S., Connolly C.N., Irving A.J., Harvey J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Mol Cell Neurosci 2007, 35:559-572.
38. Oomura Y., Hori N., Shiraishi T., Fukunaga K., Takeda H., Tsuji M., et al. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006, 27:2738-2749.
39. Farr S.A., Banks W.A., Morley J.E. Effects of leptin on memory processing. Peptides 2006, 27:1420-1425.
40. Winocur G., Greenwood C.E., Piroli G.G., Grillo C.A., Reznikov L.R., Reagan L.P., et al. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 2005, 119:1389-1395.
41. Li X.L., Aou S., Oomura Y., Hori N., Fukunaga K., Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 2002, 113:607-615.
42. Grillo CA, Piroli GG, Junor L, Wilson SP, Mott DD, Wilson MA, Reagan LP. Obesity/hyperleptinemic phenotype impairs structural and functional plasticity in the rat hippocampus. Physiol Behav, in press.
43. Lu X.Y., Kim C.S., Frazer A., Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006, 103:1593-1598.
44. Liu J., Garza J.C., Bronner J., Kim C.S., Zhang W., Lu X.Y. Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology (Berl) 2010, 207:535-545.
45. Collin M., Hakansson-Ovesjo M.L., Misane I., Ogren S.O., Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Brain Res Mol Brain Res 2000, 81:51-61.
46. Sharma A.N., Elased K.M., Garrett T.L., Lucot J.B. Neurobehavioral deficits in db/db diabetic mice. Physiol Behav 2010, 101:381-388.
47. Kamei J., Miyata S., Morita K., Saitoh A., Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2003, 75:247-254.
48. Ramanathan M., Jaiswal A.K., Bhattacharya S.K. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology (Berl) 1998, 135:361-367.
49. Jung S.W., Han O.K., Kim S.J. Increased expression of beta amyloid precursor gene in the hippocampus of streptozotocin-induced diabetic mice with memory deficit and anxiety induction. J Neural Transm 2010, 117:1411-1418.
50. Hirano S., Miyata S., Kamei J. Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2007, 86:27-31.
51. Banks W.A., Coon A.B., Robinson S.M., Moinuddin A., Shultz J.M., Nakaoke R., et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
52. Farr S.A., Yamada K.A., Butterfield D.A., Abdul H.M., Xu L., Miller N.E., et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008, 149:2628-2636.
53. Ikegaya Y., Ishizaka Y., Matsuki N. BDNF attenuates hippocampal LTD via activation of phospholipase C: implications for a vertical shift in the frequency-response curve of synaptic plasticity. Eur J Neurosci 2002, 16:145-148.
54. Desai N.S., Rutherford L.C., Turrigiano G.G. BDNF regulates the intrinsic excitability of cortical neurons. Learn Mem 1999, 6:284-291.
55. Asztely F., Kokaia M., Olofsdotter K., Ortegren U., Lindvall O. Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus. Eur J Neurosci 2000, 12:662-669.
56. Maffei L. Plasticity in the visual system: role of neurotrophins and electrical activity. Arch Ital Biol 2002, 140:341-346.
57. Shirayama Y., Chen A.C.H., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22:3251-3261.
58. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
59. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007, 101:239-244.
60. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
61. Pandey S.C., Zhang H., Roy A., Misra K. Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J Neurosci 2006, 26:8320-8331.
62. Bornstein S.R., Schuppenies A., Wong M.L., Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006, 11:892-902.
63. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005, 54:20-23.
64. Dalvi A., Lucki I. Murine models of depression. Psychopharmacology (Berl) 1999, 147:14-16.
65. Nair A., Vadodaria K.C., Banerjee S.B., Benekareddy M., Dias B.G., Duman R.S., et al. Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology 2007, 32:1504-1519.